Background Transcatheter aortic valve replacement (TAVR) has increasingly emerged as one of the primary treatments for ...
In response to the growing burden of non-communicable diseases (NCDs), health experts have called for stronger cardiac and neurological care ...
As of publication, the delivery system is FDA approved or commercially available. Corcym said this first human procedure ...
New medical advancements are making surgery less invasive for those with Aortic Valve Disease. When the aortic heart valve ...
Older patients with coronary artery disease scheduled for transcatheter aortic valve replacement (TAVR) had comparable ...
JenaValve today announced the successful first cases and official U.S. commercial launch of its Trilogy heart valve system.
The notifications show promise for getting more patients at least evaluated by a multidisciplinary heart team within 90 days.
Clinical Trials Arena on MSN
Tempus’ automated alerts boost patient outcomes in valvular heart disease
The EHR-based alert system is designed to improve treatment equity in valvular diseases like MR and AS.
NEW ORLEANS—An artificial intelligence model trained to analyze electrocardiogram (ECG) images identified which patients had ...
Introduction International guidelines emphasise the role of heart valve centres (HVC) and specialist heart valve clinics ...
Hybrid cardiac imaging techniques enhance coronary artery disease diagnosis, physiologic assessment, risk stratification, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results